Miravant Medical Technologies Inc. (MRVT)
MRVT Stock Price Chart
Explore Miravant Medical Technologies Inc. interactive price chart. Choose custom timeframes to analyze MRVT price movements and trends.
MRVT Company Profile
Discover essential business fundamentals and corporate details for Miravant Medical Technologies Inc. (MRVT) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
11 Apr 1995
Employees
47.00
CEO
David E. Mai
Description
Miravant Medical Technologies Inc. operates as a pharmaceutical research and development company. The company develops PhotoPoint, a photodynamic therapy that responds to light destroying cancerous cells; and manufactures light producing and light delivery devices. Its products include PHOTREX for the treatment of wet age-related macular degeneration or AMD; MV9411, a photoreactive drug for the treatment of plaque psoriasis; MV0633 for the treatment of atherosclerosis, atherosclerotic vulnerable plaque, and restenosis; MV2101 for the treatment of vascular access graft disease in hemodialysis patients; and MV6401 for the treatment of solid tumors. Miravant Medical Technologies Inc. was formerly known as PDT, Inc. and changed its name to Miravant Medical Technologies Inc. in September 1997. The company was founded in 1989 and is headquartered in Santa Barbara, California.
MRVT Financial Timeline
Browse a chronological timeline of Miravant Medical Technologies Inc. corporate events including earnings releases, dividend announcements, and stock splits.
MRVT Stock Performance
Access detailed MRVT performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.